Both in Pharmaceuticals
Cytokinetics vs Madrigal Pharmaceuticals
Over the past year CYTK returned +3.8% and MDGL returned −3.9%; their daily moves had a correlation of 0.24.
CYTK +3.8% MDGL −3.9%Growth of $1, one year, split-adjusted
| Metric | CYTK | MDGL |
|---|---|---|
| Price | $62.31 | $396.32 |
| Market cap | $8.66B | $9.16B |
| Today | +0.45% | −8.08% |
| 1 month | −0.6% | −19.7% |
| 6 months | −19.2% | −21.1% |
| Year to date | −1.9% | −31.9% |
| 1 year | −2.0% | −5.4% |
| Revenue growth (YoY) | −57.1% | +71.2% |
| Gross margin | 90.5% | 100.0% |
| Net margin | −694.4% | −15.9% |
| P/E (TTM) | — | — |
| Price / sales | 128.0× | 7.1× |
| Net cash | $18.6M | $498.0M |
| Dividend yield | — | — |
| Volatility (60d) | 31.7% | 35.1% |
| Short % of float | 15.4% | 14.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).